First-In-Class Drug BBI608 Tested In Patients With Advanced Cancer

Researchers at Boston Biomedical, Inc., are working to develop a novel first-in-class cancer drug that works by targeting the stem like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity... http://mnt.to/f/3BsQ